We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nmc Health Plc | LSE:NMC | London | Ordinary Share | GB00B7FC0762 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 938.40 | 940.00 | 941.60 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMNMC
RNS Number : 0744F
NMC Health Plc
24 October 2018
NMC Health plc
PDMR notification
London, 24 October 2018: NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 17 countries, announces that on 22(nd) October 2018, a trust of which Mr. Henry James Mark Tompkins (an Independent Non-Executive Director and Joint Chairman of the Company) is a beneficiary, sold a total of 800 ordinary shares of 10p each in the Company ("Shares") at a price of 3218 pence per share.
Following this transaction, Mr Tompkins has an interest over a total of 54,283 shares, representing approximately 0.026% of the issued share capital of the Company.
The Notification of Dealing Form for Mr Tompkins can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name H. J. Mark Tompkins --------------------- ----------------------------------------------------- b) Position/status Joint Non Executive Chairman --------------------- ----------------------------------------------------- c) Initial notification Initial notification /Amendment --------------------- ----------------------------------------------------- 2 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument, type of instrument --------------------- ----------------------------------------------------- b) Nature of Sale of shares made through a company owned by Tiger the transaction Trust, of which Mark Tompkins is a beneficiary --------------------- ----------------------------------------------------- c) SALE Price(s) Price No. of shares and volume(s) 3218 pence 800 -------------- --------------------- ----------------------------------------------------- d) Aggregated information - volume - Price 800 - Total 3218 pence GBP25,744 --------------------- ----------------------------------------------------- e) Date of the 22 October 2018 transaction --------------------- ----------------------------------------------------- f) Place of the London Stock Exchange transaction --------------------- -----------------------------------------------------
Contacts
Investors NMC Simon Watkins, Group Company Secretary +44 (0)20 3205 7313 Media: FTI Consulting, London Brett Pollard +44 (0)20 3727 1000 FTI Consulting, Gulf Shane Dolan +971 (0)4 437 2100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHMIBJTMBJTBMP
(END) Dow Jones Newswires
October 24, 2018 09:34 ET (13:34 GMT)
1 Year Nmc Health Chart |
1 Month Nmc Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions